Chemotherapy of NSCLC With or Without Icotinib

NCT02430974 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Icotinib

Sponsor

Nanfang Hospital, Southern Medical University